ASX - By Stock
|
PAA |
Re:
PAA - General discussions
|
|
NZ Trader
|
102 |
32K |
7 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
102
|
32K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
9 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
421
|
119K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
NZ Trader
|
68 |
19K |
5 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
68
|
19K
|
5
|
|
ASX - By Stock
|
ATC |
Re:
Ann: Altech - Extension to Entitlement Issue Closing Date
|
|
NZ Trader
|
4 |
1.1K |
2 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
4
|
1.1K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
SNT - Media thread
|
|
NZ Trader
|
14 |
5.6K |
12 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
14
|
5.6K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
NZ Trader
|
68 |
19K |
6 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
68
|
19K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
15 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
421
|
119K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
14 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
421
|
119K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
NZ Trader
|
68 |
19K |
8 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
68
|
19K
|
8
|
|
ASX - By Stock
|
NTI |
Re:
MST Access valuation
|
|
NZ Trader
|
11 |
4.3K |
5 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
11
|
4.3K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
5 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
421
|
119K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Update - Notification regarding unquoted securities - SNT
|
|
NZ Trader
|
6 |
1.9K |
3 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
6
|
1.9K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
7 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
421
|
119K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
14 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
421
|
119K
|
14
|
|
ASX - By Stock
|
NTI |
Re:
MST Access valuation
|
|
NZ Trader
|
11 |
4.3K |
3 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
11
|
4.3K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
21 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
421
|
119K
|
21
|
|
ASX - By Stock
|
NTI |
Re:
MST Access valuation
|
|
NZ Trader
|
11 |
4.3K |
3 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
11
|
4.3K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
NZ Trader
|
68 |
19K |
5 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
68
|
19K
|
5
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Appeals lodged against Exploration Permit for Penikat
|
|
NZ Trader
|
87 |
21K |
2 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
87
|
21K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
NZ Trader
|
81 |
29K |
5 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
81
|
29K
|
5
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Appeals lodged against Exploration Permit for Penikat
|
|
NZ Trader
|
87 |
21K |
5 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
87
|
21K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
NZ Trader
|
68 |
19K |
7 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
68
|
19K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
28 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
421
|
119K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Extraordinary results
|
|
NZ Trader
|
5 |
2.6K |
8 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
5
|
2.6K
|
8
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Appeals lodged against Exploration Permit for Penikat
|
|
NZ Trader
|
87 |
21K |
3 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
87
|
21K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
44
|
11K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
45 |
13K |
3 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
45
|
13K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Oversold x5
|
|
NZ Trader
|
28 |
7.6K |
20 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
28
|
7.6K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
45 |
13K |
5 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
45
|
13K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
45 |
13K |
1 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
45
|
13K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Oversold x5
|
|
NZ Trader
|
28 |
7.6K |
7 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
28
|
7.6K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
11 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
421
|
119K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Oversold x5
|
|
NZ Trader
|
28 |
7.6K |
8 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
28
|
7.6K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
2 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
44
|
11K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Oversold x5
|
|
NZ Trader
|
28 |
7.6K |
12 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
28
|
7.6K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Oversold x5
|
|
NZ Trader
|
28 |
7.6K |
8 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
28
|
7.6K
|
8
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Appeals lodged against Exploration Permit for Penikat
|
|
NZ Trader
|
87 |
21K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
87
|
21K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
SNT - Research & Valuation
|
|
NZ Trader
|
24 |
5.9K |
5 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
24
|
5.9K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
SNT - Research & Valuation
|
|
NZ Trader
|
24 |
5.9K |
4 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
24
|
5.9K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
SNT - Research & Valuation
|
|
NZ Trader
|
24 |
5.9K |
6 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
24
|
5.9K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
44
|
11K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Presentation to Extraordinary General Meeting
|
|
NZ Trader
|
4 |
923 |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
4
|
923
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
81K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
317
|
81K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
SNT - Research & Valuation
|
|
NZ Trader
|
24 |
5.9K |
6 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
24
|
5.9K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
81K |
11 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
317
|
81K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
15 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
421
|
119K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
4 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
421
|
119K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
4 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
44
|
11K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
421 |
119K |
9 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
421
|
119K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
7 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
44
|
11K
|
7
|
|